NL-OMON28430招募中不适用
Observing a Decade of Yearly Standardised Surveillance in EVAR-patients with Ultrasound or CT-Scan.
Academic Medical Center, Amsterdam, the Netherlands0 个研究点目标入组 1,997 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,997
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Age above 17 years
- •- Patients that underwent EVAR between 2007 and 2012
排除标准
- •- Connective tissue disease
- •- Patients that objected to their retrospective data being used
研究者
相似试验
招募中
不适用
The yield of a yearly surveillance program for the early detection of pancreatic cancer and its precursor lesions in high-risk individualspancreatic cancercancer of the pancreasPancreatic ductal adenocarcinoma1001799010017991NL-OMON54674Erasmus MC, Universitair Medisch Centrum Rotterdam700
撤回
不适用
A 12-month Longitudinal, Prospective, Observational, Natural History Study of Patients with Sanfilippo Syndrome Type A (MPS IIIA)MPS IIIASanfilippo syndrome Type A1002742410057167NL-OMON32977Shire Human Genetic Therapies5
已完成
不适用
The observational study on annual medical checkup at Mishima town, Onuma-gun, Fukushimaordinary people (people attending the annual medical checkups)JPRN-UMIN000036620Fukushima Prefectural Miyashita Hospital150
进行中（未招募）
1 期
A research study to collect long term safety information from subjects who have received study treatment from a qualifying lenabasum Corbus trial.Dermatomyositis (DM) is a rare and serious autoimmune disease.An overactive immune response causes chronic inflammation,which results in growth of scar tissue in the skin,muscles,and many internal organs.Cystic Fibrosis (CF) is a genetic disorder which results in thick mucus formation on the airways leading to increased lung infections,fibrosis of the lungs and digestive tract and abnormal immune functionMedDRA version: 20.0Level: PTClassification code 10012503Term: DermatomyositisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 20.0Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2020-001762-11-ATCorbus Pharmaceuticals, Inc.100
尚未招募
不适用
A 12-month, non-interventional, observational multinational study to evaluate effectiveness, tolerability, and quality of life of brivaracetam adjunctive therapy in earlier treatment lines in adult patients with history of partial-onset seizures in daily clinical practice.DRKS00025524Parexel International (IRL) Limited (Clinical Research Organisation)600